Carboplatin/gemcitabine/paclitaxelAllergic reaction and drug ineffective following off-label treatment: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1976卷 / 1期

关键词：

D O I：

10.1007/s40278-023-46827-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：98 / 98

相关论文

共 50 条

[1] AdalimumabTreatment ineffective following off-label use: case report
Reactions Weekly, 2022, 1912 (1) : 17 - 17
[2] PaclitaxelAllergic reaction and off label use: case report
Reactions Weekly, 2023, 1938 (1) : 1042 - 1042
[3] Multiple drugsVarious toxicities following off-label use and misuse, and drug ineffective: case report
Reactions Weekly, 2022, 1887 (1) : 509 - 509
[4] Carboplatin/paclitaxel/pembrolizumabAsthenia, nausea and neutropenia following off-label treatment: case report
Reactions Weekly, 2021, 1845 (1) : 115 - 115
[5] Carboplatin/paclitaxelAllergic reaction: case report
Reactions Weekly, 2017, 1673 (1) : 113 - 113
[6] Carboplatin/gemcitabine/paclitaxelAnaphylactic shock, lack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1903 (1) : 113 - 113
[7] Carboplatin/paclitaxelAllergic reaction: case report
Reactions Weekly, 2018, 1683 (1) : 186 - 186
[8] Carboplatin/paclitaxelAllergic reaction: case report
Reactions Weekly, 2018, 1724 (1) : 101 - 101
[9] InfliximabDrug ineffective and off-label use: case report
Reactions Weekly, 2025, 2051 (1) : 147 - 147
[10] BaricitinibDrug ineffective in unapproved condition following off-label use: case report
Reactions Weekly, 2023, 1938 (1) : 306 - 306

← 1 2 3 4 5 →